Through GiveTrack’s integration with Uphold, users can now donate to charitable projects with multiple traditional currencies and cryptocurrencies.

Today we announce a partnership with Uphold, the leading digital money platform, to have our donation tracking platform GiveTrack integrated with Uphold via API. Users will be able to donate to any of the charitable projects on the GiveTrack platform using 30+ supported currencies, including 23 traditional currencies, 12 digital assets, and 4 commodities. Previously, donations on GiveTrack were only made in bitcoin.

Connie Gallippi, Founder and Executive Director of BitGive, said: “This is an extremely exciting and long-awaited partnership for us, as we’re now able to open up our platform to a whole new audience. The integration with Uphold truly makes GiveTrack accessible to anyone, anywhere, and still allows our users to have a completely transparent and seamless donation tracking experience.”

Uphold is the creator of an open, trusted, and transparent digital money platform that lets users quickly and safely access traditional currencies, cryptocurrencies, and other investments all in one place. Uphold has powered more than $4 billion in transactions across 184 countries, in more than 30 supported currencies and four commodities.

Robin O’Connell, Chief Revenue Officer of Uphold, said: “It has been inspiring working with BitGive while also being able to leverage the Uphold platform. Uphold is always looking for real-world use cases and to facilitate non-speculative transactions. Here is a perfect example of how blockchain and cryptocurrencies can be applied in the philanthropic ecosystem. To provide donors a previously non-existent level of transparency and efficiency while ensuring recipients get the most out of their funding.”

In addition to several new Venezuelan projects, GiveTrack has also launched a new project in partnership with the Ukrainian Bone Marrow Donor Registry. Donations will support the registration of new bone marrow donors to help support the fight against blood cancer.

Learn more: